LAUREN BOWMAN: Open Payments
NPI 1083102057 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,464 in 107 payments from 19 companies in 2025. Trend: 2023 $730 · 2024 $921 · 2025 $3,464
Food & beverage: $3,349Education: $115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $915 |
| Janssen Biotech, Inc. | 24 | $645 |
| Madrigal Pharmaceuticals | 6 | $316 |
| Regeneron Healthcare Solutions, Inc. | 7 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $251 |
| Lilly USA, LLC | 6 | $195 |
| Ipsen Biopharmaceuticals, Inc | 4 | $185 |
| Amgen Inc. | 3 | $168 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
Products named: TREMFYA, SKYRIZI, REZDIFFRA, DUPIXENT, ENTYVIO, IQIRVO, UPLIZNA, RINVOQ.
Industry payments across TX — which companies pay providers there.
